Paysign to Host Third Quarter 2026 Earnings Call

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss third quarter 2026 earnings at 5:00 p.m. Eastern time on Monday, November 9, 2026. Participant details are as follows: U.S. dial-in: 877.407.2988 International dial-in: +1.201.389.0923 Webcast: Click Here Replay: Dial-in: 877.660.6853.

Business Wire • Oct 13, 2026

Beyond Bank Earnings: 4 Best Financial Stocks For Rising Rates

The best financial stocks to combat rising rates and inflation in Q4 may be those with superior growth and momentum, not traditional banks and brokerages. Persistent inflation and elevated interest rates raise the importance of finding companies capable of growing revenue and earnings despite tighter financial conditions. Consumer finance and digital payments offer secular growth opportunities as borrowing needs and increasingly digital financial behavior support demand.

Seeking Alpha • Oct 7, 2026

Top Stocks Averaging 100% Forward EPS Growth To Combat AI Capex Fatigue

AI capex fatigue may encourage investors to broaden their search for fundamentally strong growth stocks beyond companies dependent on massive AI infrastructure spending. Strong forward EPS growth can identify companies whose improving fundamentals and operating leverage may support continued earnings expansion independent of AI spending. Diversifying exposure across consumer finance, healthcare payments, and health insurance can reduce reliance on the AI infrastructure investment cycle.

Seeking Alpha • Sep 2, 2026

Paysign Targets $117M Revenue as Patient-Affordability Business Surges

Paysign NASDAQ: PAYS operates in two healthcare-focused businesses: payment services for plasma donors and pharmaceutical patient-affordability programs, Chief Financial Officer Jeff Baker said during a company presentation.

MarketBeat • Aug 28, 2026

Paysign (PAYS) Upgraded to Buy: What Does It Mean for the Stock?

Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research • Aug 26, 2026

Paysign (PAYS) is an Incredible Growth Stock: 3 Reasons Why

Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research • Aug 26, 2026

Paysign, Inc. to Present at the 17th Annual Midwest IDEAS Investor Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the 17th Annual Midwest IDEAS Investor Conference to be held August 26-27, 2026 at the InterContinental in Chicago, Illinois. The conference is an annual invitation-only event, featuring quality public comp.

Business Wire • Aug 18, 2026

Are Business Services Stocks Lagging Paysign (PAYS) This Year?

Here is how Paysign, Inc. (PAYS) and Sezzle Inc. (SEZL) have performed compared to their sector so far this year.

Zacks Investment Research • Aug 13, 2026

3 Reasons Growth Investors Will Love Paysign (PAYS)

Paysign (PAYS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research • Aug 10, 2026

Paysign Q2 Earnings Call Highlights

Paysign NASDAQ: PAYS reported record second-quarter revenue, net income and adjusted EBITDA for 2026, driven primarily by continued expansion in its Patient Affordability business and improving utilization in its plasma donor compensation operations.

MarketBeat • Aug 6, 2026